Sentence examples for evolution of pharmaceuticals from inspiring English sources
Radicals including Foucault and RD Laing are equated with the evolution of pharmaceuticals (there's a jar of Largactil on display) when they represent diametrically opposed attitudes.
Directed evolution is a powerful strategy for protein engineering; however, evolution of pharmaceutical proteins has been limited by the reliance of current screens on binding interactions.
As such some of the earlier mentioned factors that drive evolution of pharmaceutical expenditure at the macro level are out of our study scope and data set.
Evolution of the Pharmaceutical-Biotech Ecosystem The pharmaceutical industry is adopting principles of supply chain integration, and, according to Robert McCarthy, thus changing the processes for discovery of new drugs, along with career choices for scientists.
In many ways, the investigations are a response to the evolution of the pharmaceutical business, which has grown in the last quarter-century from a small group of companies peddling a few antibiotics and antianxiety remedies to a $400 billion behemoth that is among the most profitable industries on earth.
During the last decade the evolution of the pharmaceutical dosage form design has been important.
This study explores this relationship by analyzing the evolution of a successful Irish pharmaceutical network involving organizations from industry and academia.
In the evolution of NMR in the pharmaceutical industry, the unique strengths of NMR to provide dynamic and atomic level information continue to be exploited to discover and design new drugs.
The evolution of saturated solutions of such pharmaceutical excipients as lactose and mannitol in a liquid bridge was studied on a system situated on a microscope slide.
The SARM approach and its extensions are presented here in context to introduce different types of applications and provide an example for the evolution of a computational methodology in pharmaceutical research.
Many agricultural applications of pharmaceuticals employ subtherapeutic doses that incidentally favor drug resistance evolution in pathogenic microbes.
